Education
About Us
Working with TipRanks
Follow Us
Pacific Biosciences (PACB)
NASDAQ:PACB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 154.01M | $ 200.52M | $ 128.30M | $ 130.51M | $ 78.89M |
| Gross Profit | $ 37.28M | $ 52.78M | $ 49.03M | $ 58.86M | $ 32.57M |
| Operating Income | $ -356.38M | $ -334.47M | $ -304.82M | $ -178.16M | $ -104.39M |
| EBITDA | $ -356.38M | $ -277.28M | $ -282.24M | $ -250.76M | $ 38.97M |
| Net Income | $ -309.85M | $ -306.74M | $ -296.93M | $ -181.22M | $ 29.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 389.93M | $ 631.42M | $ 772.32M | $ 1.04B | $ 318.81M |
| Total Assets | $ 1.26B | $ 1.75B | $ 1.77B | $ 2.01B | $ 413.98M |
| Total Debt | $ 672.43M | $ 933.93M | $ 957.37M | $ 953.75M | $ 42.00M |
| Net Debt | $ 617.06M | $ 754.02M | $ 632.28M | $ 493.02M | $ -276.81M |
| Total Liabilities | $ 753.85M | $ 1.04B | $ 1.20B | $ 1.22B | $ 78.49M |
| Stockholders' Equity | $ 506.59M | $ 701.30M | $ 562.90M | $ 790.99M | $ 335.49M |
| Cash Flow | |||||
| Free Cash Flow | $ -212.25M | $ -268.02M | $ -280.14M | $ -117.11M | $ 18.46M |
| Operating Cash Flow | $ -206.06M | $ -259.17M | $ -263.21M | $ -111.18M | $ 19.50M |
| Investing Cash Flow | $ 124.00M | $ 4.60M | $ 116.08M | $ -678.53M | $ -219.32M |
| Financing Cash Flow | $ -42.99M | $ 108.89M | $ 9.62M | $ 1.17B | $ 251.84M |